Israel thành lập chính phủ liên minh do ông Netanyahu làm Thủ tướng

(Baothanhhoa.vn) - Chính phủ mới tại Israel ngày 29/12 đã tuyên thệ nhậm chức, sau khi Quốc hội nước này thông qua với 63 phiếu thuận và 54 phiếu chống trong tổng số 120 nghị sỹ. Đây là chính phủ thứ 6 do Thủ tướng Benjamin Netanyahu dẫn đầu và là chính phủ liên minh cánh hữu nhất trong lịch sử nước này. Chính phủ thứ 37 của Israel có 30 bộ trưởng và 3 thứ trưởng, nhưng chỉ có 5 đại diện là nữ giới.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh